France's corporate tax hike to impact FY25 earnings: Barclays By Investing.com
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 12 2025
0mins
Should l Buy ?
Source: Investing.com
Corporate Tax Increase in France: The French Parliament has approved a one-time increase in corporate tax rates for 2025, raising taxes on companies with revenues between EUR 1-3bn from 25% to 30.2%, and those exceeding EUR 3bn from 25% to 35.3%.
Market Impact: The announcement led to a significant drop in Aptar Pharma's stock by about 10%, while analysts predict that companies like L'Oreal and JDE Peet may see a 1% impact on their FY25 EPS estimates due to the tax changes.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
